Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasms × Acitretin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Exanthema 1

Interventions

Dexamethasone 7 Oxycodone 6 Propofol 4 Epoetin Alfa 4 Zoledronic Acid 3 Sevoflurane 3 Palonosetron 3 Ondansetron 3 Naloxone 3 Everolimus 3 Cholecalciferol 3 Calcium Dobesilate 3 Bevacizumab 3 Aspirin 3 Aprepitant 3 peginterferon alfa-2a 2 edoxaban 2 apixaban 2 apatinib 2 Vitamin B 12 2 Vancomycin 2 Tobacco Use Cessation Devices 2 Tablets 2 Surgical Procedures, Operative 2 Sodium Chloride 2 Saline Solution 2 Rivaroxaban 2 Octreotide 2 Morphine 2 Metoclopramide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01299220 2013-01-16

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

University of Pittsburgh

Phase 4 Withdrawn

Exanthema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡